BayBridge Capital Group’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$292K Buy
1,324
+384
+41% +$106K 0.15% 88
2026
Q1
$257K Hold
940
0.16% 87
2025
Q4
$257K Buy
940
+39
+4% +$10.6K 0.16% 87
2025
Q3
$243K Buy
+901
New +$245K 0.16% 87

Other funds holding CME

BayBridge Capital Group's CME Position: Q2 2026 in Review

BayBridge Capital Group increased its CME Group (CME) stake by 41% in Q2 2026, buying an estimated $106K and bringing the position to 1,324 shares worth $292K. The position accounts for 0.15% of the portfolio, ranked #88.

BayBridge Capital Group first reported a position in CME in Q3 2025 and has held it in 4 quarters since. 315 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • BayBridge Capital Group held 1,324 shares of CME Group worth $292K as of Q2 2026.
  • BayBridge Capital Group bought 384 CME Group shares in Q2 2026, an estimated $106K.
  • CME Group made up 0.15% of BayBridge Capital Group's portfolio in Q2 2026, its #88 holding.
  • BayBridge Capital Group first reported a position in CME Group in Q3 2025 and has held it in 4 quarters since.
  • 315 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on BayBridge Capital Group's 13F filing for Q2 2026, filed 14 Jul 2026.